[1] Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

[2] benzoylated uronic acid building blocks and synthesis of n-uronate conjugates of lamotrigine

[3] validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma and saliva

[4] the effect of lamotrigine and levetiracetam on tms-evoked eeg responses depends on stimulation intensity

[5] severe drug eruptions due to lamotrigine in japan based on data from the relief system of the pharmaceuticals and medical devices agency